Trxade Health Inc (MEDS)

Date: O: H: L: C: Vol:

Trxade Health Inc Stock (MEDS) Forecast

The Trxade Health Inc (MEDS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.923, representing a -44.79% decrease from the current price of $1.67. The highest analyst price target is $1.45, and the lowest is $0.3997.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month MEDS Price Target

Average 0.7392 (-55.79% Downside)

Is Trxade Health Inc (MEDS) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	33.66	Neutral
STOCH(9,6)	11.08	Buy
STOCHRSI(14)	2.92	Buy
MACD(12,26)	-0.31	Sell
ADX(14)	38.47	Buy
William %R	-96.32	Buy
CCI(14)	-80.62	Neutral

Buy: 4 · Sell: 1 · Neutral: 2Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	2.01 Sell	2.01 Sell
MA20	2.45 Sell	2.31 Sell
MA50	2.49 Sell	2.41 Sell
MA100	1.81 Sell	0.00 Buy
MA200	0.91 Buy	0.00 Buy

Buy: 3 · Sell: 7 · Neutral: 0Summary: Sell

According to our latest analysis, MEDS could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MEDS, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 33.66 indicates that MEDS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 11.08 indicates that MEDS is oversold. This indicates that MEDS price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.92 indicates that MEDS is oversold. This suggests that MEDS price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 38.47 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -80.62 indicates that MEDS is still oversold but not to an extreme extent.

Long-term MEDS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Trxade Health Inc financial reports and earnings history, Trxade Health Inc (MEDS) stock could reach $11.25 by 2030, $39.29 by 2040 and $11.86 by 2050. See the projected annual prices until 2050 of the Trxade Health Inc stock below:

Trxade Health Inc (MEDS) is expected to reach an average price of $8.40 in 2035, with a high prediction of $14.89 and a low estimate of $4.54. This indicates an +402.71% change from the last recorded price of $1.67.
Trxade Health Inc (MEDS) stock is projected to chart a bullish course in 2040, with an average price target of $1.31, representing an -21.87% change from its current level. The forecast ranges from a conservative $0.00142 to a sky-high $39.29.
Our analysts predict Trxade Health Inc (MEDS) to change +516.51% by 2045, soaring from $9.79 to an average price of $10.31, potentially reaching $10.98. While $9.79 is the low estimate, the potential upside is significant.
Trxade Health Inc (MEDS) stock is expected to climb by 2050, reaching an average of $3.78, a +125.98% change from its current level. However, a wide range of estimates exists, with high and low targets of $11.86 and $0.4574, respectively, highlighting the market's uncertainty.

Trxade Health Inc Stock (MEDS) Year by Year Forecast

Trxade Health Inc Stock (MEDS) Price Forecast for 2026

The predicted value for Trxade Health Inc (MEDS) in 2026 is set at an average of $1.86. Estimates vary from a peak of $12.31 to a trough of $0.3997, indicating an +11.05% surge from the present price of $1.67.

Month	Average	Low	High	Change from today's price
December, 2026	$0.6463	$0.3997	$1.45	-61.34%

Trxade Health Inc Stock (MEDS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Trxade Health Inc (MEDS) is $0.4707, with a high forecast of $1.38 and a low forecast of $0.0321. This indicates an -71.84% decrease from the last price of $1.67.

Month	Average	Low	High	Change from today's price
January, 2027	$0.0528	$0.0339	$0.7929	-96.84%
February, 2027	$0.1908	$0.2306	$0.164	-88.59%
March, 2027	$0.2777	$0.3342	$0.2843	-83.39%
April, 2027	$0.6787	$0.0321	$1.38	-59.40%
May, 2027	$0.3582	$0.078	$0.6923	-78.57%
June, 2027	$0.3317	$0.5016	$0.5384	-80.16%
July, 2027	$0.5553	$0.5119	$0.3601	-66.78%
August, 2027	$0.2622	$0.3954	$0.4237	-84.31%
September, 2027	$0.4758	$0.3456	$0.2558	-71.54%
October, 2027	$0.6693	$0.6792	$0.676	-59.96%
November, 2027	$0.8262	$0.7154	$0.7162	-50.58%
December, 2027	$0.9698	$0.9779	$0.9488	-41.99%

Trxade Health Inc Stock (MEDS) Price Forecast for 2028

In 2028, Trxade Health Inc (MEDS) is projected to reach an average price of $3.33, with a high projection of $18.10 and a low estimate of $1.03. This indicates an +99.11% rise from the last price of $1.67.

Month	Average	Low	High	Change from today's price
January, 2028	$1.26	$1.03	$1.20	-24.53%
February, 2028	$1.40	$1.30	$1.31	-16.24%
March, 2028	$1.37	$1.42	$1.35	-17.76%
April, 2028	$1.41	$1.35	$1.29	-15.44%
May, 2028	$1.37	$1.33	$1.30	-18.10%
June, 2028	$1.41	$1.37	$1.39	-15.73%
July, 2028	$1.27	$1.30	$1.37	-23.97%
August, 2028	$1.30	$1.32	$1.35	-22.06%
September, 2028	$11.45	$1.34	$18.10	+584.78%
October, 2028	$5.85	$5.70	$12.80	+250.00%
November, 2028	$5.39	$4.67	$11.88	+222.27%
December, 2028	$6.45	$4.76	$12.84	+286.06%

Trxade Health Inc Stock (MEDS) Price Forecast for 2029

The 2029 price forecast for Trxade Health Inc Stock (MEDS) is $7.18 on average, with a high prediction of $43.24 and a low estimate of $2.33. This represents an +329.60% increase from the previous price of $1.67.

Month	Average	Low	High	Change from today's price
January, 2029	$5.50	$4.51	$6.46	+228.82%
February, 2029	$4.26	$3.64	$5.47	+155.03%
March, 2029	$4.54	$3.61	$4.81	+171.57%
April, 2029	$3.50	$3.30	$5.09	+109.08%
May, 2029	$2.80	$2.43	$3.71	+67.46%
June, 2029	$6.88	$2.33	$12.56	+311.30%
July, 2029	$22.76	$6.47	$43.24	+1,261%
August, 2029	$5.15	$5.01	$14.61	+207.79%
September, 2029	$4.50	$4.04	$5.80	+169.26%
October, 2029	$5.37	$4.15	$6.19	+221.22%
November, 2029	$15.74	$5.42	$18.00	+841.60%
December, 2029	$5.19	$5.19	$22.58	+210.72%

Trxade Health Inc Stock (MEDS) Price Forecast for 2030

Trxade Health Inc Stock (MEDS) is expected to reach an average price of $1.99 in 2030, with a high forecast of $11.25 and a low forecast of $0.1258. This signifies an +18.87% surge from the last price of $1.67.

Month	Average	Low	High	Change from today's price
January, 2030	$5.29	$5.13	$9.08	+216.49%
February, 2030	$1.91	$1.75	$6.57	+14.10%
March, 2030	$0.1254	$0.1258	$2.63	-92.50%
April, 2030	$2.06	$0.1578	$11.25	+23.05%
May, 2030	$1.60	$1.59	$3.60	-4.08%
June, 2030	$0.45	$0.47	$2.06	-73.08%
July, 2030	$1.77	$0.5668	$1.08	+6.10%
August, 2030	$2.02	$1.72	$1.65	+20.88%
September, 2030	$2.28	$2.22	$2.33	+36.67%
October, 2030	$2.45	$2.42	$2.29	+46.66%
November, 2030	$2.06	$2.45	$2.41	+23.16%
December, 2030	$1.82	$1.71	$1.79	+9.04%

Similar to MEDS